Skip to content

Comprehensive analysis of the effects of the COVID-19 epidemic on the treatment, blood, urine and physical data of diabetic patients and dietary habits

Comprehensive analysis of the effects of the SARS-CoV-2 epidemic on the treatment, blood, urine and physical data of diabetic patients and dietary habits - Comprehensive analysis of the effects of the SARS-CoV-2 epidemic on the treatment, blood, urine and physical data of diabetic patients and dietary habits

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044851
Enrollment
6000
Registered
2021-07-13
Start date
2021-06-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

None listed

Sponsors

The University of Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients who visited the University of Tokyo Hospital as outpatients from January 2019 to March 2021 and for whom medication was administered for diabetes treatment, and all patients with diabetic type by blood sampling

Exclusion criteria

Exclusion criteria: Those who have applied to opt out

Design outcomes

Primary

MeasureTime frame
Blood test data Urinalysis data Physical measurements Lifestyle habits

Countries

Japan

Contacts

Public ContactKanako Okuma

The University of Tokyo Department of Diabetes and Metabolic Diseases

okumak-int@h.u-tokyo.ac.jp03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026